With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Trk-Targeted Therapy of Human Neuroblastomas||Children's Hospital of Philadelphia / Garrett Brodeur, M.D.||Bridge Grants||2014||Pennsylvania|
|The Tumor Suppressive Role of LNK (SH2B3) in Acute Lymphoblastic Leukemia||Children's Hospital of Philadelphia / Wei Tong, PhD||Innovation Grants||2014||Pennsylvania|
|Targeting the Accomplices of MYC in MYC-driven Medulloblastoma||Sanford-Burnham Medical Research Institute / Robert Wechsler-Reya, Ph.D.||Innovation Grants||2014||California|
|Ca2+ Release Activated Ca2+ (CRAC) Channels in Control of Leukemic Cell Metabolism and Leukemia Stem Cell Maintenance in T-ALL||New York University School of Medicine / Mate Maus, PhD||Young Investigator Grants||2014||New York|
|Targeted Inhibition of the DNA Damage Response Pathway: A Novel Intervention in the Treatment of Pediatric Leukemias||National Cancer Institute / Andre Nussenzweig, Ph.D.||Reach Grants||2014||Maryland|
|Targeting the Thymic Stromal Lymphopoeitin Receptor Signaling Axis to Reduce Relapse of High Risk Pediatric Acute Lymphoblastic Leukemia||National Cancer Institute / Christopher Chien, PhD||Young Investigator Grants||2014||Maryland|
|Identification of Rhabdomyosarcoma Therapies Using an Efficient Mouse and Drosophila Repurposing Screen||Memorial Sloan-Kettering Cancer Center / Mary Baylies, Ph.D.||Reach Grants||2014||New York|
|Modeling the Multi-hit Pathogenesis of t(12;21) Associated Pediatric ALL by CRISPR/Cas-mediated Genome Engineering||Massachusetts General Hospital / Hanno Hock, M.D., Ph.D.||Innovation Grants||2014||Massachusetts|
|Targeting Aberrant Hh Signaling with BET Bromodomain Inhibition as a Novel Therapeutic Strategy Against MB and DIPG||Lucile Packard Children's Hospital at Stanford University School of Medicine / Yujie Tang, PhD||Young Investigator Grants||2014||California|
|Investigation of Oncogenic Long Non-coding RNAs in Ewing sarcoma||Lucile Packard Children's Hospital at Stanford University School of Medicine / Siu Ping Ngok, PhD||Young Investigator Grants||2014||California|